Covid-19 Data Analyses in Brazil

Trial Identifier: D7000R00020
Sponsor: AstraZeneca
Start Date: November 2024
Primary Completion Date: November 2024
Study Completion Date: November 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Brazil Sao Paulo, Brazil